Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis

Background: Collagenous colitis is characterised by diarrhoea, lymphocytic inflammation, and a thickened subepithelial collagen layer in the colorectal mucosa. No standard treatment of the disease is established. Aims: To investigate the clinical and histological effect of oral budesonide (Entocort,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bonderup, O K, Hansen, J B, Birket-Smith, L, Vestergaard, V, Teglbjærg, P S, Fallingborg, J
Formato: Artigo
Idioma:Inglês
Publicado: Copyright 2003 by Gut 2003
Assuntos:
Inflammation and Inflammatory Bowel Disease
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1774966/
https://ncbi.nlm.nih.gov/pubmed/12524408
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares